Did you sign up for a Medicare Advantage plan during the annual election period in the fall — also known as open enrollment — only to realize it might not be the best fit? Good news — you ...
Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...
Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S ...
The drug’s global sales were estimated to be about $28 billion last year, according to FactSet. Novo Nordisk said Friday it is opposed to the Medicare negotiation program because it could hurt ...
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a ... according to the data firm FactSet.
NORWALK, Conn., Jan. 15, 2025 (GLOBE NEWSWIRE) -- FactSet, a global financial digital platform and enterprise solutions provider, today announced the launch of Pitch Creator, a groundbreaking ...
Medicare usually requires that people are 65 years old or above to qualify for a plan. However, some individuals can qualify for Medicare earlier if they have a disability or certain medical ...
Q1 GAAP revenues of $568.7 million, up 4.9% from Q1 2024.Organic Q1 ASV of $2,258.8 million, up 4.5% year over year.Q1 GAAP operating margin of 33.6%, down approximately 120 bps year over year ...
The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...
As we near the turnover of administrations, Health Affairs Forefront offers a series of articles from leaders at the Centers for Medicare and Medicaid Services offering their thoughts on the major ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Medicare covers insulin and a variety of antidiabetic drugs, including sulfonylureas, biguanides, thiazolidinediones, and alpha-glucosidase inhibitors. Original Medicare (parts A and B) and ...